Health-Related Quality of Life as Measured by the 36-Item Short Form Survey Among Adults With Acute Bacterial Skin and Skin Structure Infections who Received Either Omadacycline or Linezolid in a Phase 3 Double-Blind, Double-Dummy Clinical Trial | Zendy

Surya Chitra | Zendy; Jordan Hinahara | Zendy; Thomas F. Goss | Zendy; Kyle Gunter | Zendy; Kenneth LaPensee | Zendy

Open Access

Health-Related Quality of Life as Measured by the 36-Item Short Form Survey Among Adults With Acute Bacterial Skin and Skin Structure Infections who Received Either Omadacycline or Linezolid in a Phase 3 Double-Blind, Double-Dummy Clinical Trial

Author(s) -

Surya Chitra,

Jordan Hinahara,

Thomas F. Goss,

Kyle Gunter,

Kenneth LaPensee

Publication year - 2021

Publication title -

open forum infectious diseases

Language(s) - English

Resource type - Journals

SCImago Journal Rank - 1.546

H-Index - 35

ISSN - 2328-8957

DOI - 10.1093/ofid/ofab459

Subject(s) - linezolid , medicine , quality of life (healthcare) , bacteria , staphylococcus aureus , nursing , vancomycin , biology , genetics

This analysis of data from a Phase 3 study of adults with acute bacterial skin and skin structure infections showed that successful oral treatment with omadacycline (n = 368) or linezolid (n = 367) was associated with improvement in health-related quality of life.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.

Having issues? You can contact us here

Accelerating Research